These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26239981)

  • 1. Protective effect of Qnr on agents other than quinolones that target DNA gyrase.
    Jacoby GA; Corcoran MA; Hooper DC
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6689-95. PubMed ID: 26239981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
    Tran JH; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jan; 49(1):118-25. PubMed ID: 15616284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of plasmid-mediated quinolone resistance.
    Tran JH; Jacoby GA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5638-42. PubMed ID: 11943863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of a GyrBA fusion protein and its interaction with QnrB and quinolones.
    Chen C; Villet R; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7124-7. PubMed ID: 26324265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.
    Cesaro A; Bettoni RR; Lascols C; Mérens A; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 May; 61(5):1007-15. PubMed ID: 18325893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
    Pan XS; Gould KA; Fisher LM
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3822-31. PubMed ID: 19564360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli.
    Yue L; Jiang HX; Liao XP; Liu JH; Li SJ; Chen XY; Chen CX; Lü DH; Liu YH
    Vet Microbiol; 2008 Dec; 132(3-4):414-20. PubMed ID: 18573620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Qnr on Plasmid Gyrase Toxins CcdB and ParE.
    Kwak YG; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5078-9. PubMed ID: 26055367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli GyrA Tower Domain Interacts with QnrB1 Loop B and Plays an Important Role in QnrB1 Protection from Quinolone Inhibition.
    Chen C; Wang Y; Nakaminami H; Kim ES; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0040221. PubMed ID: 33846132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
    Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
    Aubry A; Pan XS; Fisher LM; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1281-8. PubMed ID: 15047530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of plasmid-mediated resistance to quinolones].
    Rodríguez-Martínez JM
    Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):25-31. PubMed ID: 15701330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms.
    Li XZ
    Int J Antimicrob Agents; 2005 Jun; 25(6):453-63. PubMed ID: 15890498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
    Flatman RH; Howells AJ; Heide L; Fiedler HP; Maxwell A
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to quinolones.
    Jacoby GA
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S120-6. PubMed ID: 15942878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.